Pharmaceutical & Cosmetic Raw Materials Supplier-OCTAGON CHEMICALS LIMITED

High Purity Cetilistat 282526-98-1

High Purity Cetilistat 282526-98-1

Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.

Cetilistat is a drug designed to treat obesity  It acts in the same way as the older drug orlistat (Xenical) by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. There are speculations that Cetilistat is gonna replace Orlistat as the No.1 Weight-Loss Agent.

Cetilistat acts as a gastrointestinal lipase inhibitor that blocks fat digestion and absorption, leading to reduced energy intake, and thus weight loss. It is distinct from most other anti-obesity agents as it does not act on the brain to reduce appetite, but acts peripherally. The compound remains in the gastrointestinal tract with no significant absorption into the body.

Clinical Trials phase II has completed, showing promising results. Let's wait and see when it will take over the market share of Orlistat.

Chemical Facts of High Purity Cetilistat
Cas No.:  282526-98-1
Formula C25H39NO3
Molar mass 401.582 g/mol
Purity: 99.0% as min

Documents Available for High Purity Cetilistat: COA/MSDS/HPLC/H1NMR
Disclaimer:Those products (High Purity Cetilistat 282526-98-1) PATENTED are for lab analytical & research purposes only.